GOLDSTEIN DOV A MD

CIK 1120478 · View on SEC EDGAR ↗

Insider

First SEC filing: Sept. 25, 2024 · Latest: Sept. 25, 2024

On this page

Insider at

Insider transactions

0 buys (P) 4 sells (S) Net: $-531,844 + 49 non-open-market transactions below last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

49 other filings hidden
Date Ticker Code Shares Price Value Owned after Δ own A/D vs now
Jan. 13, 2026 BIOA S 10b5-1 1,923 $21.08 $40,537 22,408 Direct -7.90% Disposed -53.7% (price as of 2026-08-21)
Jan. 13, 2026 BIOA S 10b5-1 11,663 $20.54 $239,558 24,331 Direct -32.40% Disposed -52.4% (price as of 2026-08-21)
Jan. 13, 2026 BIOA S 10b5-1 4,440 $19.45 $86,358 35,994 Direct -10.98% Disposed -49.8% (price as of 2026-08-21)
Jan. 13, 2026 BIOA S 10b5-1 8,974 $18.43 $165,391 40,434 Direct -18.16% Disposed -47.0% (price as of 2026-08-21)
March 22, 2017 ESPR S 312,642 $38.82 $12,136,762 837,125 Indirect -27.19% Disposed
March 21, 2017 ESPR S 487,358 $43.48 $21,190,326 1,149,767 Indirect -29.77% Disposed
April 24, 2015 ESPR S 61,726 $106.10 $6,549,129 1,837,125 Indirect -3.25% Disposed
April 24, 2015 ESPR S 5,743 $108.00 $620,244 1,898,851 Indirect -0.30% Disposed
April 23, 2015 ESPR S 150,000 $109.10 $16,365,000 1,904,594 Indirect -7.30% Disposed
July 1, 2013 ESPR P 238,119 $14.00 $3,333,666 2,054,594 Indirect +13.11% Acquired

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Derivative holdings (Form 4 Table II)

Options, RSUs and convertible securities reported on Form 4 Table II.

Date Ticker Security Underlying Exercise price Expiration Shares A/D
July 15, 2026 GANX Stock Option (right to buy) Common Stock (25,000) $1.68 July 15, 2036 25,000 Acquired
April 23, 2026 BIOA Stock Option (Right to Buy) Common Stock (3,542) $4.38 Feb. 17, 2035 3,542 Disposed
March 1, 2026 BIOA Stock Option (Right to Buy) Common Stock (3,542) $4.38 Feb. 17, 2035 3,542 Disposed
Feb. 17, 2026 BIOA Stock Option (Right to Buy) Common Stock (110,000) $19.63 Feb. 16, 2036 110,000 Acquired
Feb. 1, 2026 BIOA Stock Option (Right to Buy) Common Stock (3,541) $4.38 Feb. 17, 2035 3,541 Disposed
Jan. 16, 2026 BIOA Stock Option (Right to Buy) Common Stock (3,542) $4.38 Feb. 17, 2035 3,542 Disposed
Jan. 13, 2026 BIOA Stock Option (Right to Buy) Common Stock (27,000) $8.39 April 16, 2034 27,000 Disposed
Jan. 2, 2026 COYA Stock Option (right to buy) Common Stock, par value $0.0001 per share (10,000) $5.65 Jan. 2, 2036 10,000 Acquired
Feb. 25, 2025 COYA Stock Option (right to buy) Common Stock, par value $0.0001 per share (5,000) $5.97 Feb. 25, 2035 5,000 Acquired
Jan. 1, 2025 COYA Stock Option (right to buy) Common Stock, par value $0.0001 per share (5,000) $5.73 Jan. 1, 2035 5,000 Acquired
June 23, 2023 GANX Stock Option (right to buy) Common Stock (10,500) $4.50 June 23, 2033 10,500 Acquired
Sept. 20, 2022 GANX Stock Option (right to buy) Common Stock (10,500) $3.50 Sept. 20, 2032 10,500 Acquired
Feb. 28, 2020 ADMA Employee Stock Option (right to buy) Common Stock (15,000) $2.92 Feb. 28, 2030 15,000 Acquired
March 13, 2019 ADMA Stock Option (right to buy) Common Stock (30,000) $3.89 March 13, 2029 30,000 Acquired
June 22, 2018 ADMA Stock Option (right to buy) Common Stock (17,500) $4.91 June 22, 2028 17,500 Acquired
June 6, 2018 ESPR Stock Option (right to buy) Common Stock (8,000) $17.75 June 9, 2026 8,000 Acquired
June 6, 2018 ESPR Stock Option (right to buy) Common Stock (5,000) $14.42 May 15, 2024 5,000 Acquired
May 23, 2018 ESPR Stock Option (right to buy) Common Stock (10,100) $38.32 May 23, 2028 10,100 Acquired
Dec. 18, 2017 ESPR Stock Option (right to buy) Common Stock (21,471) $3.70 April 11, 2023 21,471 Disposed
June 6, 2017 ADMA Stock Option (right to buy) Common Stock (53,837) $3.66 June 6, 2027 53,837 Acquired
April 17, 2017 ESPR Stock Option (right to buy) Common Stock (14,000) $38.96 April 17, 2027 14,000 Acquired
Feb. 14, 2017 ADMA Stock Option (right to buy) Common Stock (10,000) $5.00 Feb. 14, 2027 10,000 Acquired
June 9, 2016 ESPR Stock Option (right to buy) Common Stock (8,000) $17.75 June 9, 2026 8,000 Acquired
Jan. 28, 2016 ADMA Options to purchase Common Stock (9,000) — Jan. 28, 2026 9,000 Acquired
May 14, 2015 ESPR Stock Option (right to buy) Common Stock (8,000) $107.74 May 14, 2025 8,000 Acquired
Jan. 30, 2015 ADMA Options to purchase Common Stock (9,000) — Jan. 30, 2025 9,000 Acquired
June 19, 2014 ADMA Options to purchase Common Stock (9,000) — June 18, 2024 9,000 Acquired
May 15, 2014 ESPR Stock Option (right to buy) Common Stock (5,000) $14.42 May 15, 2024 5,000 Acquired
July 1, 2013 ESPR Warrant to Purchase Common Stock Common Stock (71,237) — Feb. 12, 2018 71,237 Acquired
July 1, 2013 ESPR Warrant to Purchase Preferred Stock Series A Preferred Stock (497,666) — Feb. 12, 2018 497,666 Disposed
July 1, 2013 ESPR Series A Preferred Stock Common Stock (1,816,475) — — 1,816,475 Disposed
April 4, 2012 ADMA Stock Option Common Stock (13,258) $9.60 April 3, 2022 13,258 Acquired

Exercise/conversion price is blank when not applicable (e.g. RSUs).

Initial ownership (Form 3) 8 holdings

Securities held when first becoming an insider, per SEC Form 3.

Date Ticker Security Shares Ownership
Sept. 25, 2024 BIOA Common Stock 22,408 Direct
Sept. 25, 2024 BIOA Stock Option (Right to Buy)→ Common Stock (128,331) 128,331 Direct
Sept. 25, 2024 BIOA Stock Option (Right to Buy)→ Common Stock (119,587) 119,587 Direct
Dec. 28, 2022 COYA Stock Option (right to buy)→ Common Stock, par value $0.0001 per share — Direct
March 17, 2021 GANX Stock Option→ Common Stock (10,000) 10,000 Direct
June 25, 2013 ESPR Series A Preferred Stock→ Common Stock (1,816,475) 1,816,475 Indirect
June 25, 2013 ESPR Warrant to Purchase Preferred Stock→ Series A Preferred Stock — Indirect
June 25, 2013 ESPR Stock Option (right to buy)→ Common Stock (21,471) 21,471 Direct